Abstract
Objective: Mechanical thrombectomy (MT) is an effective treatment for large vessel occlusion (LVO) with a high successful recanalization (SR) rate. However, MT fails in a proportion of patients, leading to poor clinical outcomes. We analyzed the factors associated with the failure of MT.
Methods: A total of 648 consecutive patients with MT were enrolled. MT failure was defined as 0,1, or 2a of modified Thrombolysis in Cerebral Infarction (mTICI) grade. Failed MTs were divided into 3 categories, reaching failure, passage failure, and recanalization failure (RF). Various factors in RF and SR groups were analyzed with 1: 1 propensity score matching.
Results: Failed MT was observed in 97 patients (14.3%). Among them, 69 patients (10.2% of the entire cohort, 71.1% of the failed MT group) were included in the RF group. Propensity matching analysis with 69 patients in each group showed that the RF group had a higher rate of residual intracranial atherosclerotic stenosis (ICAS) than the SR group (30.4% vs. 14.5% P = 0.003). The rates of 4 or more passages and no change of method were significantly higher in the RF group than in the SR group (34.8% vs. 13.0%; P = 0.001 and 28.9% vs. 8.7%; P = 0.001).
Conclusion: The failure rate for all of the MT was approximately 15%, and RF accounted for more than 70% of the failed MT. RF was associated with residual ICAS. In cases with RF, even in repeated attempts for recanalization, an alteration of the thrombectomy method should be considered.
[http://dx.doi.org/10.1016/S0140-6736(16)00163-X] [PMID: 26898852]
[http://dx.doi.org/10.1056/NEJMoa1411587] [PMID: 25517348]
[http://dx.doi.org/10.1056/NEJMoa1414792] [PMID: 25671797]
[http://dx.doi.org/10.1056/NEJMoa1415061] [PMID: 25882376]
[http://dx.doi.org/10.1056/NEJMoa1414905] [PMID: 25671798]
[http://dx.doi.org/10.1056/NEJMoa1503780] [PMID: 25882510]
[http://dx.doi.org/10.1136/neurintsurg-2017-013558] [PMID: 29222393]
[PMID: 34125952]
[http://dx.doi.org/10.2174/1567202617666191223143831] [PMID: 31870263]
[http://dx.doi.org/10.1056/NEJMoa1706442] [PMID: 29129157]
[http://dx.doi.org/10.1056/NEJMoa0804656] [PMID: 18815396]
[http://dx.doi.org/10.3340/jkns.2020.0046] [PMID: 32759627]
[http://dx.doi.org/10.1159/000210432] [PMID: 19342825]
[http://dx.doi.org/10.1136/neurintsurg-2018-014114] [PMID: 30054319]
[http://dx.doi.org/10.1161/STROKEAHA.113.001972] [PMID: 23920012]
[http://dx.doi.org/10.1136/neurintsurg-2018-014060] [PMID: 30472671]
[http://dx.doi.org/10.7759/cureus.8875] [PMID: 32617250]
[http://dx.doi.org/10.1136/neurintsurg-2021-017985] [PMID: 34429348]
[http://dx.doi.org/10.1136/neurintsurg-2018-014586] [PMID: 30954938]
[http://dx.doi.org/10.1136/neurintsurg-2021-017871] [PMID: 34551992]
[http://dx.doi.org/10.1016/j.wneu.2019.02.140] [PMID: 30851472]
[http://dx.doi.org/10.1136/neurintsurg-2019-015347] [PMID: 32015181]
[http://dx.doi.org/10.1016/j.wneu.2018.12.216] [PMID: 30677582]
[http://dx.doi.org/10.1007/s00062-019-00777-1] [PMID: 30895349]
[http://dx.doi.org/10.1136/neurintsurg-2016-012391] [PMID: 27166383]
[http://dx.doi.org/10.1136/neurintsurg-2017-013226] [PMID: 28798266]
[http://dx.doi.org/10.1155/2017/7565702] [PMID: 29123937]
[http://dx.doi.org/10.3340/jkns.2020.0146] [PMID: 33715323]
[http://dx.doi.org/10.1227/NEU.0000000000000694] [PMID: 25988927]
[http://dx.doi.org/10.3892/etm.2017.4856] [PMID: 28912883]
[http://dx.doi.org/10.1136/neurintsurg-2022-018683] [PMID: 35428740]
[http://dx.doi.org/10.2174/1567202616666191023154956] [PMID: 31702492]
[http://dx.doi.org/10.2174/1567202615666180605104931] [PMID: 29875001]
[http://dx.doi.org/10.1136/neurintsurg-2018-014380] [PMID: 30389897]